$CYTK..Long in Coming but 2015 Brings Increasing Visibility on a Phase III in ALS; Upgrading to OverWeight w/ target price at $13..." (Piper Jaffray) h/t @tomsilver39
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.